|
Real-time
Oslo Bors
08:00:20 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.480 NOK | +1.22% |
|
+2.06% | -63.48% |
Company Valuation: Elliptic Laboratories ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,882 | 2,295 | 1,786 | 1,103 | 714.9 | 309.5 | - | - |
| Change | - | -20.36% | -22.15% | -38.24% | -35.2% | -56.7% | - | - |
| Enterprise Value (EV) 1 | 2,681 | 2,129 | 1,697 | 1,046 | 671.8 | 242.5 | 258.7 | 266.5 |
| Change | - | -20.57% | -20.32% | -38.34% | -35.79% | -63.91% | 6.67% | 3.01% |
| P/E | -252x | -71.1x | -47.3x | 116x | -5.14x | -9.9x | -49.6x | 51.8x |
| PBR | 8.41x | 7.04x | 5.82x | 3.39x | 3.8x | 1.46x | 1.46x | 1.39x |
| PEG | - | -0x | -2.9x | -1x | 0x | 0.1x | 0.6x | -0x |
| Capitalization / Revenue | 45.7x | 44.1x | 26.1x | 8.36x | 6.96x | 3.03x | 2.55x | 2.05x |
| EV / Revenue | 42.5x | 40.9x | 24.8x | 7.93x | 6.54x | 2.37x | 2.13x | 1.76x |
| EV / EBITDA | -948x | -69.1x | -50.6x | 41.7x | -32.5x | -41x | 14.7x | 7.37x |
| EV / EBIT | -241x | -50.5x | -34.1x | 222x | -14.8x | -7.7x | -29.4x | 33.5x |
| EV / FCF | -94.3x | -59x | - | - | -29.1x | -9.7x | -25.9x | -266x |
| FCF Yield | -1.06% | -1.69% | - | - | -3.44% | -10.3% | -3.87% | -0.38% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.11 | -0.31 | -0.36 | 0.09 | -1.32 | -0.2475 | -0.0494 | 0.0473 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 63.04 | 52.06 | 68.32 | 131.9 | 102.7 | 102.2 | 121.3 | 151.3 |
| EBITDA 1 | -2.829 | -30.81 | -33.52 | 25.12 | -20.68 | -5.917 | 17.56 | 36.17 |
| EBIT 1 | -11.14 | -42.13 | -49.74 | 4.71 | -45.44 | -31.5 | -8.792 | 7.947 |
| Net income 1 | -11.16 | -32.04 | -37.85 | 8.96 | -139 | -32.05 | -6.465 | 6.262 |
| Net Debt 1 | -201 | -165.5 | -89.72 | -57.04 | -43.06 | -67.03 | -50.86 | -43.07 |
| Reference price 2 | 27.750 | 22.050 | 17.040 | 10.480 | 6.790 | 2.450 | 2.450 | 2.450 |
| Nbr of stocks (in thousands) | 103,842 | 104,074 | 104,838 | 105,275 | 105,287 | 126,337 | - | - |
| Announcement Date | 10/03/22 | 17/02/23 | 15/02/24 | 27/02/25 | 26/02/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.9x | 2.37x | -40.99x | -.--% | 32.56M | |
| -439.56x | 8.46x | 31.61x | -.--% | 30.43B | |
| 162.13x | 0.95x | 13.12x | -.--% | 7.82B | |
| 20.17x | - | - | - | 5.84B | |
| 64.96x | 1.95x | 11.59x | -.--% | 3.99B | |
| -44.98x | - | - | - | 1.52B | |
| 21.96x | - | - | - | 442M | |
| 132x | 4.63x | 14.98x | - | 380M | |
| Average | -11.65x | 3.67x | 6.06x | 0% | 6.31B | |
| Weighted average by Cap. | -232.70x | 6.44x | 26.14x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ELABS Stock
- Valuation Elliptic Laboratories ASA
Select your edition
All financial news and data tailored to specific country editions
